Scribe Therapeutics Inc.
Ownership
Ownership Structure
Who owns Scribe Therapeutics Inc. (SCTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 36.4% of the shares are freely tradable; institutional investors hold 53.1%.
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Genomic Revolution ETF | 4.16 | 731,127 | +0.4 | 09/29/2026 |
| T. Rowe Price Health Sciences | 3.89 | 683,719 | +19.2 | 08/31/2026 |
| Franklin Biotechnology Discv A(acc)USD | 1.39 | 244,433 | +0.0 | 08/31/2026 |
| iShares Russell 2000 ETF | 1.37 | 241,563 | +0.9 | 09/29/2026 |
| Franklin Biotechnology Discovery A | 0.77 | 135,567 | +0.0 | 08/31/2026 |
| iShares Russell 2000 Growth ETF | 0.30 | 52,973 | -0.8 | 09/29/2026 |
| T. Rowe Price Health Sciences Port | 0.23 | 40,334 | +22.1 | 08/31/2026 |
| ARK Genomic Revolution ETF A USD Acc | 0.23 | 40,324 | +1.7 | 09/29/2026 |
| iShares Micro-Cap ETF | 0.17 | 30,740 | +0.0 | 09/29/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 0.09 | 15,461 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.